Long-term use of glucocorticoids at high and low doses significantly increases CV risk, with an unfavorable impact on lipid metabolism, obesity, insulin production, insulin resistance, and blood pressure [22,36,99]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.